Company profile
Cipher Pharmaceuticals Inc.
OTC: CPHRF · Healthcare · Medical - Pharmaceuticals
Canadian filerHQ Mississauga, ONReports USD
#434 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
84B+FH 92DQ —GM 74SS 56
v0.1 · 45/100 weight · provisional
↑ net margin, operating margin · ↓ workforce scale, disclosure history
Methodology →Revenue TTM
$49.3M
Rev growth YoY (TTM)
+3.7%
Net income (FY)
$27.8M
Employees
6
as of 2026-08-13
Market cap
$258.0M
as of 2026-08-13
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$51.3M$51.3M2025
Net income$27.8M$27.8M2025
Operating income$16.8M$16.8M2025
Total assets$156.2M$156.2M2025
Liabilities$30.2M$30.2M2025
Equity$126.0M$126.0M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Cipher Pharmaceuticals Inc.’s revenue?
Cipher Pharmaceuticals Inc. booked $51.3M in FY2025 revenue, growing 54% year over year — faster than most Healthcare companies we track, at a 54.2% net margin.
Peers · Healthcare
Ocular Therapeutix, Inc.62CNeptune Wellness Solutions Inc.——LENSAR Inc55CCarlsmed, Inc.54DMinerva Surgical, Inc.——Charlotte's Web Holdings, Inc.44DKey facts
CEOCraig J. Mull
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersMississauga, ON
ExchangeOTC: CPHRF
Employees6
IPO date2006-02-02
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.